HomePTIX • NASDAQ
Protagenic Therapeutics Inc
add
$0.30
15.92%
After Hours:(12.10%)-0.036
$0.26
Closed: Apr 11, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.64M | 35.55% |
Net income | -1.55M | 7.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.63M | -37.53% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.84M | -54.67% |
Total assets | 1.96M | -54.76% |
Total liabilities | 942.76K | 43.88% |
Total equity | 1.01M | — |
Shares outstanding | 7.53M | — |
Price to book | 1.85 | — |
Return on assets | -237.16% | — |
Return on capital | -474.31% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.55M | 7.30% |
Cash from operations | -819.79K | 28.37% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 1.60M | — |
Net change in cash | 782.66K | -31.02% |
Free cash flow | -293.03K | 67.48% |
Previous close
$0.26
Day range
$0.26 - $0.30
Year range
$0.18 - $1.87
Market cap
2.25M USD
Avg Volume
10.61M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
1994
Website
Employees
2
